Cargando…

Metabolic Phenotypes: Drivers of Health Outcomes in Fatty Liver Diseases

Detalles Bibliográficos
Autor principal:	Charatcharoenwitthaya, Phunchai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318285/ https://www.ncbi.nlm.nih.gov/pubmed/37408813 http://dx.doi.org/10.14218/JCTH.2022.00170S

Ejemplares similares

Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease
por: Rugivarodom, Manus, et al.
Publicado: (2022)

Dietary Composition and Its Association with Newly Diagnosed Nonalcoholic Fatty Liver Disease and Insulin Resistance
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2021)

Muscle strength, but not body mass index, is associated with mortality in patients with non‐alcoholic fatty liver disease
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2022)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2021)

Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients
por: Saokaew, Surasak, et al.
Publicado: (2020)

Cigarette Smoking Increased Risk of Overall Mortality in Patients With Non-alcoholic Fatty Liver Disease: A Nationwide Population-Based Cohort Study
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2020)

Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2021)

Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients
por: Phisalprapa, Pochamana, et al.
Publicado: (2017)

Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome
por: Kositamongkol, Chayanis, et al.
Publicado: (2021)

Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Li, Xia, et al.
Publicado: (2018)

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Bibbò, Stefano, et al.
Publicado: (2018)

Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis
por: Rugivarodom, Manus, et al.
Publicado: (2020)

Value and risk of percutaneous liver biopsy in patients with cirrhosis and clinical suspicion of autoimmune hepatitis
por: Sripongpun, Pimsiri, et al.
Publicado: (2021)

No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease
por: Biquard, Louise, et al.
Publicado: (2020)

Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome
por: Boonchai, Punyisa, et al.
Publicado: (2022)

Fructoholism in adults: The importance of personalised care in metabolic dysfunction-associated fatty liver disease
por: Salavrakos, Mélissa, et al.
Publicado: (2021)

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

Metabolic drivers of non-alcoholic fatty liver disease
por: Bence, Kendra K., et al.
Publicado: (2020)

Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis
por: Charatcharoenwitthaya, Phunchai, et al.
Publicado: (2021)

Sa110 IMPACT OF COVID-19 PANDEMIC ON THE MANAGEMENT AND CLINICAL OUTCOMES OF PATIENTS ADMITTED WITH UPPER GASTROINTESTINAL BLEEDING
por: Manomaiwong, Ekawat, et al.
Publicado: (2021)

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Hong, Jian-Guo, et al.
Publicado: (2022)

Importance of Variables in Nonalcoholic Fatty Liver Disease Patients
por: Garg, Vivek Kumar, et al.
Publicado: (2018)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Dysregulation of follicle fatty acid is a potential driver of human primary ovarian insufficiency
por: Wang, Lina, et al.
Publicado: (2020)

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19
por: Targher, G., et al.
Publicado: (2020)

Liver- Heart Inter- Relationship in Fatty Liver Disease Based on the Avicenna’s Point of View
por: KHADEM, Ebrahim, et al.
Publicado: (2013)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Revised Nomenclature for Fatty Liver Disease: Cutting through the Confusion
por: Alsawat, Khalid, et al.
Publicado: (2020)

Acute Fatty Liver of Pregnancy
por: Dey, Madhusudan, et al.
Publicado: (2012)

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Hye Won
Publicado: (2023)

Development and validation of a 90-day mortality prediction model following endobiliary drainage in patients with unresectable malignant biliary obstruction
por: Termsinsuk, Panotpol, et al.
Publicado: (2022)

The Effects of COVID-19 on Clinical Outcomes of Non-COVID-19 Patients Hospitalized for Upper Gastrointestinal Bleeding during the Pandemic
por: Pausawasdi, Nonthalee, et al.
Publicado: (2022)

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Jeong, Seogsong, et al.
Publicado: (2023)

Lack of genetic evidence that fatty liver disease predisposes to COVID-19
por: Valenti, Luca, et al.
Publicado: (2020)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cpanmbcn3ttag0a8bdd411dp9h